Cite
Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1.
MLA
Marchand, M., et al. “Tumor Regressions Observed in Patients with Metastatic Melanoma Treated with an Antigenic Peptide Encoded by Gene MAGE-3 and Presented by HLA-A1.” International Journal of Cancer, vol. 80, no. 2, Jan. 1999, pp. 219–30. EBSCOhost, https://doi.org/10.1002/(sici)1097-0215(19990118)80:2<219::aid-ijc10>3.0.co;2-s.
APA
Marchand, M., van Baren, N., Weynants, P., Brichard, V., Dréno, B., Tessier, M. H., Rankin, E., Parmiani, G., Arienti, F., Humblet, Y., Bourlond, A., Vanwijck, R., Liénard, D., Beauduin, M., Dietrich, P. Y., Russo, V., Kerger, J., Masucci, G., Jäger, E., … Boon, T. (1999). Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. International Journal of Cancer, 80(2), 219–230. https://doi.org/10.1002/(sici)1097-0215(19990118)80:2<219::aid-ijc10>3.0.co;2-s
Chicago
Marchand, M, N van Baren, P Weynants, V Brichard, B Dréno, M H Tessier, E Rankin, et al. 1999. “Tumor Regressions Observed in Patients with Metastatic Melanoma Treated with an Antigenic Peptide Encoded by Gene MAGE-3 and Presented by HLA-A1.” International Journal of Cancer 80 (2): 219–30. doi:10.1002/(sici)1097-0215(19990118)80:2<219::aid-ijc10>3.0.co;2-s.